NeuroPace: Only For Those With Strong Nerves

koto_feja In February, I was last picking up the pace in the case of NeuroPace, Inc. (NASDAQ:NPCE) after shares doubled since September 2023, aided by strong operating momentum. After shares tripled in a relatively short period of time, it was an opportune time to take some profits. By now, shares have lost half their value again, increasing the appeal, yet I find it too early to add to a current small speculative position here. An Epilepsy Play NeuroPace aims to improve the lives of epilepsy patients, by r ...